Katz Michael David M.D. has filed 8 insider transactions across 1 company since January 2023.
Most recent transaction: a grant/award of 1592 shares of Hanover Bancorp, Inc. /MD ($HNVR) on February 05, 2026.
Activity breakdown: 1 open-market purchase and 1 sale.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 5, 2026 | Hanover Bancorp, Inc. /MD | $HNVR | Katz Michael David M.D. | Director | A | Common Stock | 1592 | $0.00 | 249,027.0000 | 7,280,133 | 0.64% | 0.02% |
| Jan. 29, 2025 | Hanover Bancorp, Inc. /MD | $HNVR | Katz Michael David M.D. | Director | A | Common Stock | 1331 | $0.00 | 247,435.0000 | 7,187,142 | 0.54% | 0.02% |
| Dec. 10, 2024 | Hanover Bancorp, Inc. /MD | $HNVR | Katz Michael David M.D. | Director | S | Common Stock | 5000 | $25.53 | 246,104.0000 | 7,193,854 | 1.99% | 0.07% |
| April 9, 2024 | Hanover Bancorp, Inc. /MD | $HNVR | Katz Michael David M.D. | Director | M | Common Stock | 7057 | $10.00 | 251,104.0000 | 7,163,159 | 2.89% | 0.10% |
| April 9, 2024 | Hanover Bancorp, Inc. /MD | $HNVR | Katz Michael David M.D. | Director | M | Non-Qualified Stock Option | 7057 | $0.00 | 0.0000 | 7,163,159 | 100.00% | 0.10% |
| March 1, 2024 | Hanover Bancorp, Inc. /MD | $HNVR | Katz Michael David M.D. | Director | A | Common Stock | 2117 | $0.00 | 244,047.0000 | 7,137,794 | 0.88% | 0.03% |
| Jan. 29, 2024 | Hanover Bancorp, Inc. /MD | $HNVR | Katz Michael David M.D. | Director | P | Common Stock | 700 | $18.02 | 241,930.0000 | 7,137,794 | 0.29% | 0.01% |
| Jan. 24, 2023 | Hanover Bancorp, Inc. /MD | $HNVR | Katz Michael David M.D. | Director | A | Common Stock | 1612 | $0.00 | 241,230.0000 | 7,103,911 | 0.67% | 0.02% |